We are live on ! Find out more
CA

Cambridge Advisors Portfolio holdings

AUM $582M
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
-12.32%
1 Year Est. Return
+19.14%
3 Year Est. Return
+52.94%
5 Year Est. Return
+51.55%
10 Year Est. Return
+171.25%
AUM
$366M
AUM Growth
-$53.7M
Cap. Flow
+$177K
Cap. Flow %
0.05%
Top 10 Hldgs %
55.1%
Holding
191
New
12
Increased
48
Reduced
94
Closed
14
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOO icon
1
Vanguard S&P 500 ETF
VOO
$1.02T
$60.1M 16.44%
173,391
+5,090
+3% +$1.92M
BND icon
2
Vanguard Total Bond Market
BND
$162B
$45.5M 12.44%
604,809
-31,812
-5% -$2.42M
VEA icon
3
Vanguard FTSE Developed Markets ETF
VEA
$240B
$24.4M 6.66%
597,537
+18,846
+3% +$838K
IJH icon
4
iShares Core S&P Mid-Cap ETF
IJH
$125B
$13.6M 3.71%
299,630
+7,625
+3% +$376K
BNDX icon
5
Vanguard Total International Bond ETF
BNDX
$83B
$12.8M 3.51%
259,040
-14,909
-5% -$752K
VTI icon
6
Vanguard Morningstar Total Stock Market ETF
VTI
$685B
$11.1M 3.04%
58,919
+4,819
+9% +$990K
VCIT icon
7
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.9B
$10.5M 2.88%
131,596
-661
-0.5% -$54K
MSFT icon
8
Microsoft
MSFT
$3.65T
$8.68M 2.37%
33,799
+254
+0.8% +$68.9K
AAPL icon
9
Apple
AAPL
$4.52T
$7.93M 2.17%
58,011
-3,785
-6% -$573K
VWO icon
10
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$6.94M 1.9%
166,535
-5,043
-3% -$218K
AMGN icon
11
Amgen
AMGN
$239B
$6.21M 1.7%
25,533
-54
-0.2% -$13.2K
VNQ icon
12
Vanguard Real Estate ETF
VNQ
$39.4B
$5.89M 1.61%
64,698
+7,698
+14% +$767K
BRK.B icon
13
Berkshire Hathaway Class B
BRK.B
$1.08T
$5.38M 1.47%
19,722
-475
-2% -$149K
VB icon
14
Vanguard Morningstar Small-Cap ETF
VB
$81.9B
$5.38M 1.47%
30,575
+1,400
+5% +$270K
VIG icon
15
Vanguard Dividend Appreciation ETF
VIG
$114B
$5.31M 1.45%
37,026
-1,856
-5% -$282K
UNP icon
16
Union Pacific
UNP
$184B
$3.85M 1.05%
18,075
+25
+0.1% +$5.69K
SCHG icon
17
Schwab US Large-Cap Growth ETF
SCHG
$62.3B
$3.57M 0.98%
246,508
-3,980
-2% -$63.6K
ACN icon
18
Accenture
ACN
$114B
$3.26M 0.89%
11,750
-1,700
-13% -$511K
DHR icon
19
Danaher
DHR
$152B
$3.22M 0.88%
14,314
-384
-3% -$88.4K
SCHD icon
20
Schwab US Dividend Equity ETF
SCHD
$112B
$3.12M 0.85%
130,797
+10,722
+9% +$273K
JNJ icon
21
Johnson & Johnson
JNJ
$658B
$2.83M 0.77%
15,966
-114
-0.7% -$20.3K
LOW icon
22
Lowe's Companies
LOW
$120B
$2.81M 0.77%
16,080
-1,679
-9% -$324K
FTCS icon
23
First Trust Capital Strength ETF
FTCS
$8.05B
$2.51M 0.69%
35,947
-2,088
-5% -$154K
JEPI icon
24
JPMorgan Equity Premium Income ETF
JEPI
$46.5B
$2.43M 0.66%
43,786
+21,780
+99% +$1.26M
SCHB icon
25
Schwab US Broad Market ETF
SCHB
$44.6B
$2.22M 0.61%
151,008
-8,997
-6% -$144K

Similar funds

Cambridge Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Cambridge Advisors held 191 positions worth $366M, down 13% from $420M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Cambridge Advisors's Q2 2022 filing shows 12 new, 48 increased, 94 reduced and 14 closed positions. Its largest new stake was First Trust Exchange-Traded Fund II First Trust Indxx Global Natural Resources Income ETF: 110,151 shares worth $1.47M. The largest sale was Vanguard Total Bond Market, an estimated $2.42M.

By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 9% a quarter earlier, followed by Healthcare and Industrials.

  • Cambridge Advisors's largest Q2 2022 buy was First Trust Exchange-Traded Fund II First Trust Indxx Global Natural Resources Income ETF: 110,151 shares worth $1.47M.
  • Cambridge Advisors added most to Vanguard S&P 500 ETF in Q2 2022, an estimated $1.92M increase.
  • Cambridge Advisors's biggest Q2 2022 reduction was Vanguard Total Bond Market, cutting an estimated $2.42M.
  • Cambridge Advisors fully exited ARK Genomic Revolution ETF in Q2 2022, selling an estimated $1.04M.
  • Cambridge Advisors's ten largest holdings make up 55% of its $366M portfolio in Q2 2022.
  • Cambridge Advisors opened 12 new positions and closed 14 in Q2 2022.
  • Cambridge Advisors's portfolio value fell 13% quarter-over-quarter to $366M.

Based on Cambridge Advisors's 13F filing for Q2 2022, filed 18 Jul 2022.